Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
Condition: Breast Cancer Metastatic Cancer Interventions: Drug: Apatinib; Drug: Dalpiciclib; Drug: Fulvestrant/AI Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials